Medical Condition News

RSS
NIH expected to award up to $70 million to launch Alzheimer's Clinical Trials Consortium

NIH expected to award up to $70 million to launch Alzheimer's Clinical Trials Consortium

Researchers uncover novel strategy to program immune system for fighting cancer

Researchers uncover novel strategy to program immune system for fighting cancer

Study provides new insights into mechanism of tumor survival in glioblastoma

Study provides new insights into mechanism of tumor survival in glioblastoma

Rice scientists develop method to identify patients at high risk of continued seizures before surgery

Rice scientists develop method to identify patients at high risk of continued seizures before surgery

Butler Hospital launches international Alzheimer's disease prevention study

Butler Hospital launches international Alzheimer's disease prevention study

Researchers find link between brain structure and hallucination proneness, musical aptitude

Researchers find link between brain structure and hallucination proneness, musical aptitude

Researchers discover potential regulator essential for killer T cells to reside in tumors

Researchers discover potential regulator essential for killer T cells to reside in tumors

Tgen And Baylor secure federal grant to develop early detection system for pancreatic cancer

Tgen And Baylor secure federal grant to develop early detection system for pancreatic cancer

LSUHealthNO breakthrough may pave way for advances in obesity-related diseases

LSUHealthNO breakthrough may pave way for advances in obesity-related diseases

Russian researchers create new approaches to prevention and treatment of diabetes

Russian researchers create new approaches to prevention and treatment of diabetes

Death receptors in the blood can help measure risk of cardiovascular diseases, type 2 diabetes

Death receptors in the blood can help measure risk of cardiovascular diseases, type 2 diabetes

New, more easily administered therapies offer benefits for bleeding and clotting disorders

New, more easily administered therapies offer benefits for bleeding and clotting disorders

Scientists develop software that predicts leukemia-specific immune targets

Scientists develop software that predicts leukemia-specific immune targets

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Pairing immunotherapy drug with chemotherapy proves beneficial for relapsed acute myeloid leukemia

Kidney dysfunction raises diabetes risk, study suggests

Kidney dysfunction raises diabetes risk, study suggests

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Combination of chemotherapy and targeted drug improves response in younger CLL patients

Study finds percutaneous coronary intervention as recommendable treatment for left main coronary artery disease

Study finds percutaneous coronary intervention as recommendable treatment for left main coronary artery disease

Mayo Clinic researchers find emojis to be helpful in assessing patients' quality of life

Mayo Clinic researchers find emojis to be helpful in assessing patients' quality of life

New genetic model identified for predicting outcomes in patients with primary myelofibrosis

New genetic model identified for predicting outcomes in patients with primary myelofibrosis

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

CAR T cell therapy shows long-lasting remissions in non-Hodgkin's lymphoma patients

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.